The delineation of good versus bad microbiome in the context of different cancers[208,209] is gradually being clarified; while we do not know yet how GH excess, deficit, or resistance affects the gut microbiota[210] and its response in cancer and other disease sets. The gene discussed is GH1; the disease is cancer.